Zhongzhi Pharmaceutical Holdings Limited Financial Overview
Zhongzhi Pharmaceutical Holdings Limited's market cap is currently HK$448.91M. The company's EPS TTM is HK$0.011; its P/E ratio is 20.15; and it has a dividend yield of 9.43%. Zhongzhi Pharmaceutical Holdings Limited is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
